Opioid system and human emotions
- PMID: 28394427
- PMCID: PMC6016642
- DOI: 10.1111/bph.13812
Opioid system and human emotions
Abstract
Emotions are states of vigilant readiness that guide human and animal behaviour during survival-salient situations. Categorical models of emotions posit neurally and physiologically distinct basic human emotions (anger, fear, disgust, happiness, sadness and surprise) that govern different survival functions. Opioid receptors are expressed abundantly in the mammalian emotion circuit, and the opioid system modulates a variety of functions related to arousal and motivation. Yet, its specific contribution to different basic emotions has remained poorly understood. Here, we review how the endogenous opioid system and particularly the μ receptor contribute to emotional processing in humans. Activation of the endogenous opioid system is consistently associated with both pleasant and unpleasant emotions. In general, exogenous opioid agonists facilitate approach-oriented emotions (anger, pleasure) and inhibit avoidance-oriented emotions (fear, sadness). Opioids also modulate social bonding and affiliative behaviour, and prolonged opioid abuse may render both social bonding and emotion recognition circuits dysfunctional. However, there is no clear evidence that the opioid system is able to affect the emotions associated with surprise and disgust. Taken together, the opioid systems contribute to a wide array of positive and negative emotions through their general ability to modulate the approach versus avoidance motivation associated with specific emotions. Because of the protective effects of opioid system-mediated prosociality and positive mood, the opioid system may constitute an important factor contributing to psychological and psychosomatic resilience.
Linked articles: This article is part of a themed section on Emerging Areas of Opioid Pharmacology. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v175.14/issuetoc.
© 2017 The British Pharmacological Society.
Figures
 
              
              
              
              
                
                
                 
              
              
              
              
                
                
                 
              
              
              
              
                
                
                References
- 
    - Argiolas A, Melis MR (2013). Neuropeptides and central control of sexual behaviour from the past to the present: a review. Prog Neurobiol 108: 80–107. - PubMed
 
- 
    - Bencherif B, Fuchs PN, Sheth R, Dannals RF, Campbell JN, Frost JJ (2002). Pain activation of human supraspinal opioid pathways as demonstrated by C‐11 ‐carfentanil and positron emission tomography (PET). Pain 99: 589–598. - PubMed
 
- 
    - Bergen AW, Kokoszka J, Peterson R, Long JC, Virkkunen M, Linnoila M et al. (1997). Mu opioid receptor gene variants: lack of association with alcohol dependence. Mol Psychiatry 2: 490–494. - PubMed
 
Publication types
MeSH terms
Substances
LinkOut - more resources
- Full Text Sources
- Other Literature Sources
- Research Materials
 
        